Glover Stephen C. bought PDSB
January 12, 2026 · Form 4 insider transaction
Glover Stephen C. bought 54,876 shares of PDS Biotechnology Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 50 days after the transaction.
Direction
Acquired (buy-side)
Shares
54,876
Price
$0.00
Total value
N/A
InsiderGlover Stephen C.
RoleDirector
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 12, 2026
Filing dateMarch 3, 2026
Shares owned after54,876
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.